US2002127612A1PendingUtilityA1
Growth differentiation factor-9
Est. expiryJan 12, 2013(expired)· nominal 20-yr term from priority
Inventors:Se-Jin Lee
A61P 35/00A61P 43/00A61K 39/0006C07K 14/475A61K 38/00C07K 14/495B29C 53/58B29C 53/60A61P 15/00B29L 2031/75B29L 2031/7498A61P 15/18A61P 13/02A61K 39/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Growth differentiation factor-9 (GDF-9) is disclosed along with its polynucleotide sequence and amino acid sequence. Also disclosed are diagnostic and therapeutic methods of using the GDF-9 polypeptide and polynucleotide sequences.
Claims
exact text as granted — not AI-modified1 . Substantially pure growth differentiation factor-9 (GDF-9) and functional fragments thereof.
2 . A method of detecting a cell proliferative disorder comprising contacting an antibody that specifically binds to GDF-9.
3 . The method of claim 2 , wherein the cell proliferative disorder is an ovarian tumor.
4 . The method of claim 2 , wherein the detecting is in vivo.
5 . The method of claim 4 , wherein the antibody is detectably labeled.
6 . The method of claim 5 , wherein the detectable label is selected from the group consisting of a radioisotope, a fluorescent compound, a bioluminescent compound and a chemiluminescent compound.
7 . The method of claim 2 , wherein the detection is in vitro.
8 . The method of claim 7 , wherein the antibody is detectably labeled.
9 . The method of claim 8 , wherein the label is selected from the selected from the group consisting of a radioisotope, a fluorescent compound, a bioluminescent compound, a chemiluminescent compound and an enzyme.Join the waitlist — get patent alerts
Track US2002127612A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.